0001140361-23-022490.txt : 20230502 0001140361-23-022490.hdr.sgml : 20230502 20230502163036 ACCESSION NUMBER: 0001140361-23-022490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230430 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vollins James CENTRAL INDEX KEY: 0001757833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 23879598 MAIL ADDRESS: STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL STREET 2: 4131 PARK LAKE AVE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 form4.xml X0407 4 2023-04-30 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001757833 Vollins James C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 true General Counsel false Stock Option (Right to Buy) 1.03 2023-04-30 4 A 0 120000 0 A 2033-04-29 Common Stock 120000 120000 D The option vests as to twenty-five percent of the shares upon the one-year anniversary of April 12, 2023, and in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service status as of each such date. /s/ James Vollins 2023-05-02